Standing out on the ASX

Challenge: Raise awareness for the largest biotech IPO since the 90s

At a period of market uncertainty in the biotechnology sector, Australian biotechnology company Telix Pharmaceuticals (ASX: TLX) needed to drive both institutional and retail investor awareness for its $50million initial public offering (IPO) on the ASX.

The company intended to be the biggest biotech IPO since CSL’s listing in 1994 – and a significant amount of support was needed to effectively educate the market opportunity of this late-stage clinical development company.


We developed a staged communication approach to highlight the Company’s investment proposition – demonstrating its innovative technologies, support from big name investors and corporate history.?

To effectively undertake this, we organised and managed roadshow events across the country to engage retail and institutional investors in the lead up to the IPO. This enabled investors to meet company representatives, driving a deeper understanding of Telix, its products, and its market opportunity.

We also directly engaged mainstream industry, business, and finance media throughout the IPO period and immediately listing to drive awareness and interest for Telix from the broader investment community.

Impact: A successful IPO at a time of market uncertainty

Telix Pharmaceuticals had a successful ASX listing which was largely oversubscribed at a period of market favor wavering for the biotechnology industry. Additionally;

  • Telix’s share price rose to a 21% premium on listing day – up from the IPO price of $0.65 to $0.79
  • Over 75 retail and institutional investors and analysts attended the investor briefings
  • Over 23 items of coverage were secured across mainstream business and finance, influential investor and industry media over a two month period with a potential reach of over 14,852,000
  • WE Buchan also secured a live TV broadcast interview on Sky News on listing day despite a heavy news cycle with a significant Government announcement being made on the same day